课题基金 / 基金详情

项目摘要

项目成果

ROBERT G. HOLLOWAY的其他基金

相似基金

相关文献

中文摘要
翻译
罗切斯特大学的机构职业发展计划(UR-KL 2计划)有一个 建立招聘和发展从事学科的早期职业教师(学者)的跟踪记录- 指导研究,有助于UR的整体生产力,并过渡到自我支持的翻译 研究人员。UR-KL 2计划将继续这一传统,并利用现有的优先事项, UR的方案优势,以创新和扩大其职业发展途径,以满足 不断发展的一代临床和翻译教师的个人研究需求。该方案是一致的 在罗切斯特大学临床和转化科学研究所的优先考虑和领导下, 并汇集了来自医学院16个部门和中心的33个项目教师 以及牙科、护理、艺术、科学和工程。 UR-KL 2计划旨在通过为期两年的培训,每年支持两名早期职业教师 程序.为了应对临床和转化研究日益增长的压力, 医学和NCATS的建议,UR-KL 2计划将扩大其成功的职业发展 计划(包括核心和选修课程以及指导研究项目)纳入新的、 团队科学的创新培训,并提供新颖,跨学科的个性化培训机会 研究方法和途径。这种编程方法确保UR-KL 2计划高度 响应每个学者的不同背景和职业目标,使培训和指导 经验促进成功过渡到独立的临床和翻译研究者(个人 K-或R-奖)。 为了实现这一愿景,UR-KL 2计划将遵循5个计划目标:1)提供每一个 具有正式课程和职业指导基础课程的学者,2)促进定制 学者选择的研究相关教育或与三个翻译专业之一保持一致: a)使能技术,B)监管科学,以及c)电子健康记录(EHR)作为以下方面的资源 研究,3)创造一个支持和结构化的环境,为指导研究的经验,包括 外部研究伙伴的潜在参与,4)强调团队科学的重要性, 要求基本的课程作业和应用经验,在“从事追随者”,和5)严格 通过应用定量和定性标准评估UR-KL 2计划的绩效。
英文摘要
The University of Rochester's Institutional Career Development Program (UR-KL2 Program) has an established track record of recruiting and developing early career faculty (Scholars) who engage in discipline- directed research, contribute to the overall productivity of the UR, and transition to self-supporting translational research faculty. The UR-KL2 Program will continue this legacy and capitalize on the existing priority and programmatic strengths at the UR to innovate and expand its career development pathways to meet the individual research needs of an evolving generation of clinical and translational faculty. The Program is aligned with the priorities and leadership of the University of Rochester's Clinical and Translational Science Institute and has assembled 33 Program Faculty from 16 Departments and Centers across the Schools of Medicine and Dentistry, Nursing, and Arts, Sciences and Engineering. The UR-KL2 Program is designed to support two early career faculty per year through a two-year training program. In response to growing pressures on clinical and translational research, as well as Institute of Medicine and NCATS recommendations, the UR-KL2 Program will expand its successful Career Development Program (includes core and elective coursework and mentored-research project) to incorporate new, innovative training in team science and provide individualized training opportunities in novel, cross-disciplinary research methods and approaches. This programmatic approach ensures that the UR-KL2 Program is highly responsive to each Scholar's diverse background and career goals, so that the training and mentoring experiences promote successful transition to an independent clinical and translational investigator (individual K- or R-award). To accomplish this vision, the UR-KL2 Program will be guided by 5 program objectives: 1) To provide each Scholar with a foundational curriculum of formal coursework and career guidance, 2) To promote customized research-related education of the Scholar's choosing or aligned with one of three Translational Specializations: a) Enabling Technologies, b) Regulatory Science, and c) Electronic Health Record (EHR) as a Resource for Research, 3) To create a supportive and structured environment for a mentored-research experience, including potential engagement of external research partners, 4) To emphasize the importance of team science through required fundamental coursework and applied experiences in “engaged followership”, and 5) To rigorously evaluate the performance of the UR-KL2 Program through application of quantitative and qualitative criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Rochester Clinical Site within the NEXT Network of Clinical Trials
  • 批准号:
    10189726
  • 项目类别:
  • 资助金额:
    $30.57万
  • 财政年份:
    2018
  • 负责人:
    ROBERT G. HOLLOWAY
  • 依托单位:
University of Rochester Clinical Site within the NEXT Network of Clinical Trials
  • 批准号:
    10743143
  • 项目类别:
  • 资助金额:
    $42.35万
  • 财政年份:
    2018
  • 负责人:
    ROBERT G. HOLLOWAY
  • 依托单位:
Research Project 2 will use remote assessments to engage large, novel populations of participants with Parkinson disease
  • 批准号:
    10017342
  • 项目类别:
  • 资助金额:
    $21.02万
  • 财政年份:
    2018
  • 负责人:
    ROBERT G. HOLLOWAY
  • 依托单位:
University of Rochester Clinical Site within the NEXT Network of Clinical Trials
  • 批准号:
    9975927
  • 项目类别:
  • 资助金额:
    $30.57万
  • 财政年份:
    2018
  • 负责人:
    ROBERT G. HOLLOWAY
  • 依托单位:
海外基金